PHARMACOLOGY Academic Year

Similar documents
Pharmacology 260 Online Course Schedule Summer 2015

CONTENTS SECTION 1 SECTION

Contents. SECTION 1 General Pharmacology. SECTION 2 Drugs Affecting Autonomic Nervous System

SYLLABUS FOR PHARMACOLOGY AND TOXICOLOGY COURSES

Introduction to Pharmacology

PHARMACEUTICAL SCIENCES (PHM SCI)

Pharmacology. An Introduction. Henry Hitner, Ph.D. Barbara Nagle, Ph.D. Learn. Neuroscience, Physiology,

Basic Principles in Pharmacology

INTRODUCTION. Dr Laith M Abbas Al-Huseini M.B.Ch.B, M.Sc., M.Res., Ph.D. epartment of Pharmacology and Therapeutics

Drug CHAPTER 2. Pharmacologic Principles. NDEG 26A Eliza Rivera-Mitu, RN, MSN. Pharmacology. Drug Names. Pharmacologic Principles. Drug Names (cont'd)

Syllabus 2018/2019. Description of the course. Group of detailed education results. Module/Course. Pharmacology and toxicology. preclinical science

Brand and Generic Drugs. Educational Objectives. Absorption

SUBJECT TEACHING GUIDE

SCHOOL OF EDUCATION AND HEALTH

Pharmacy Orientation PP150. Associate professor of Pharmaceutics Faculty of Pharmacy-Mansoura University

Pharmacology for CHEMISTS

Evaluating Exam Review Book and Guide

Drug Classifications

Clinical Pharmacology and Drug Therapy

VTPP 625 SECTION 500 PHARMACOLOGY Syllabus

SILLABUS FOR STUDENTS OF PHARMACEUTICAL FACULTY

Summary Public Assessment Report. Generics. Etoricoxib Aurobindo. 30 mg, 60 mg, 90 mg, 120 mg Film-coated tablet (Etoricoxib) PT/H/1603/ /DC

STANDARD COURSE SYLLABUS Pharmacology and Toxicology 4 th year Medical Faculty for academic year 2013/2014

Package Insert. Clistin Dry. 24 hours.

Basic Pharmacology. Drugs

PRODUCT INFORMATION LEAFLET

Oral Pain Medications in Your Practice Scot Morris, OD, FAAO

Fundamentals of Pharmacology

Public Assessment Report. Scientific discussion. Diliban Retard Tramadol/Paracetamol IS/H/0168/001/DC. Date:

Chapter 7. Principles of Pharmacology

NAPHCON-A Eye Drops naphazoline hydrochloride 0.025% and pheniramine maleate 0.3%.

Introducing Pharmacokinetics and Pharmacodynamics. Janice Davies Pharmacist Room 23 Maudland Building

About the PCTB Examination Assisting the Pharmacist in Serving Patients p. 1 Filling the Medication Order p. 3 Receiving the Medication Order p.

FDB FOOD AND DRUGS BOARD G H A N A GUIDELINES FOR CONDUCTING BIOEQUIVALENCE STUDIES

PACKAGE INSERT TEMPLATE FOR SALBUTAMOL TABLET & SALBUTAMOL SYRUP

Pharmacologic Principles. Dr. Alia Shatanawi

Basic Concepts of TDM

SYLLABUS OF PHARMACOLOGY FOR UNDERGRADUATE MEDICAL STUDENTS. GOAL: To inculcate a rational and scientific basis of therapeutics in a medical graduate

Pharmacodynamics & Pharmacokinetics 1

DRUG NAMING AND CLASSES

Slide 1. Slide 2. Slide 3. Drug Action and Handling. Lesson 2.1. Lesson 2.1. Drug Action and Handling. Drug Action and Handling.

Pharmacology I PHAR 400

Drug Classifications

PHARMACOLOGY-1 PHL-313. Ali Alhoshani Office: 2B 84

General Principles of Pharmacology and Toxicology

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Chapter 1: Fundamentals of Pharmacology Test Bank

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

INTERACTION DRUG BODY

LACIPIL QUALITATIVE AND QUANTITATIVE COMPOSITION

Market Share & Competition

Pharmacodynamics. Dr. Alia Shatanawi

Summary of Product Characteristics Updated 01-May-2015 Meda Pharmaceuticals

Clinical Endpoint Bioequivalence Study Review in ANDA Submissions. Ying Fan, Ph.D.

Ideal Sedative Agent. Pharmacokinetics. Benzodiazepines. Pharmacodynamics 11/11/2013

Ideal Sedative Agent. Benzodiazepines 11/12/2013. Pharmacology of Benzodiazepines Used for Conscious Sedation in Dentistry.

IUPAC Name 2-diethylaminoethyl 1- cyclohexylcyclohexane-1- carboxylate Chemical Structure. Molecular Weight

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Drug + Receptor Drug receptor complex Biologic effect

PHRM20001 NOTES PART 1 Lecture 1 History of Pharmacology- Key Principles

Chloroform Codeine Ether

Fundamentals of Pharmacology

Course Title Systematic Pharmacology I

Tablet is a major category of solid dosage forms which are widely used worldwide. Extensive information is required to prepare tablets with good

Chapter Goal. Learning Objectives 9/11/2012. Chapter 5. Emergency Pharmacology

Odactra (house dust mite allergen extract) NEW PRODUCT SLIDESHOW

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory COBADEX SYRUP

GUÍA DOCENTE ABREVIADA DE LA ASIGNATURA

Package Insert. Cognitin

Which was the greatest problem with patent medicines in early America that lead to drug legislation?

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

NEW ZEALAND DATASHEET

9. The phenomenon that occurs upon taking additional doses of acetaminophen for pain when a 100 percent response has been attained is called A.

SUMMARY OF PRODUCT CHARACTERISTICS

Basics of Pharmacology

Each 5ml of Sinarest LP New Syrup contains: Phenylephrine

GTB 214/3 BASIC PHARMACOLOGY

PHRM20001: Pharmacology - How Drugs Work!

SUMMARY OF PRODUCT CHARACTERISTICS. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each sachet contains the following active ingredients:

Instructor Information

Guidance for Industry

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Monocast Description Indications

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS

LESSON ASSIGNMENT. After completing this lesson, you should be able to: Given a group of definitions, select the definition of analgesia.

DETERMINATION OF MICROBIAL CONTAMINANTS IN SOME MARKETED HERBAL FORMULATION

Does tramadol have aspirin in it

HES 128. Pharmacology and Dosage Calculations for Allied Health Occupations

SUMMARY OF PRODUCT CHARACTERISTICS

Essentials for Medication Safety

January 25, Introduction to Pharmacology

PARACOD Tablets (Paracetamol + Codeine phosphate)

CHD 110 PSYCHOPHARMACOLOGY AND SUBSTANCE ABUSE

Autonomic Pharmacology: Cholinergic agonists

Placebo effect in clinical practice. RadwanBanimustafaMD Jordan university

The father of Western medicine, Hippocrates (460 BC BC) is known to have used many plants and herbs for medicinal purposes. Hippocrates' use of

Salapin: Salbutamol BP 2mg as sulphate in each 5mL of a raspberry cola flavoured, sugar free syrup.

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

Transcription:

PHARMACOLOGY Academic Year 2016-2017

Prof. Jean François DESAPHY Pharmacology Part I (4 CFU, 48 hours) I semester General concepts Pharmacodynamics Pharmacokinetics Toxicology notions - Adverse drug reactions and pharmacogenetics Cardiovascular Pharmacotherapy Antihypertensive drugs, anti-angina, antiarrhythmics, cardiotonics. Diuretics. Anticoagulants. Anti-hyperlipidemia drugs. Insulin and hypoglycemic agents Pharmacotherapy (6 CFU, 72 hours) II semester PHARMACOLOGY V YEAR Chemotherapy Parasitic diseases, microbial diseases, neoplastic diseases, immunotherapy Hematopoietics, antitumor hormonal therapy Prof. Monica MONTAGNANI Neuropharmacology General anesthetics, local anesthetics, hypnotics and sedatives (BZD, ethanol, ecc), anticonvulsants, analgesics (FANS, opioids, adjuvants), anti-neurodegeneratives (Parkinson, Alzheimer, dementia, others), psychiatric disorders. Drugs acting on peripheral nervous system: cholinergic agonists, anticholinesterase agents, antimuscarinic agents, catecholamines and sympathomimetic drugs, adrenergic receptor drugs. Drug addiction Pharmacotherapy (others) Anti-inflammation (histamine antagonists, eicosanoids, PAF, treatment of asthma, FANS), immunosuppression Gastrointestinal function (anti-ulcer, etc ), antiemetic agents, uterine motility Hormones and antagonists (Thyroid, estrogens, androgens, progestins, ADH). Bone and calcification. Vitamins

PHARMACOLOGY The science that deals with the origin, nature, chemistry, effects, and uses of DRUGS PHARMACOKINETICS What the body does to the drug PHARMACODYNAMICS What the drug does to the body PHARMACOLOGY PHARMACOTHERAPEUTICS Studies the use of drugs PHARMACOGNOSY Identifies crude materials as drugs TOXICOLOGY Studies the poisoning effects of drugs It includes pharmacognosy, pharmacokinetics, pharmacodynamics, pharmacotherapeutics, and toxicology.

DRUG φάρμακον WHO definition: Natural or synthetic substance which is used or intended to be used to modify or explore physiological systems or pathological states for the benefit of the recipient. Any substance that, when taken into a living body, affects its functioning or structure, and is used in the diagnosis, mitigation, treatment, or prevention of a disease or relief of discomfort. Remedy Toxic or poison

DRUG: REMEDY, TOXIC OR POISON? REMEDY: A drug can be used for the CURE when, administered in a patient with a pathological condition, is able to restore health, reduce pain or prevent complications. REMEDY: A drug can be used for the PREVENTION: when, administered in a healthy subject, is able to hinder the onset or mitigate the progression of a pathological condition. TOXIC: any substance when taken at inappropriately high doses or concentrations. POISON: a chemical substance with no beneficial effects, even when dose or concentration is very low (snake poison, poison mushrooms, heavy metals). Paracelsus (1493-1541) "All things are poison and nothing is without poison, only the dose permits something not to be poisonous." The dose makes the poison

DRUG NAME Every marketed drug has at least three names - A CHEMICAL (SYSTEMATIC) NAME: the chemical name describes the atomic or molecular structure of the drug. This name is usually too complex for general use. - A GENERIC (NON PROPRIETARY) NAME: the generic name identifies the drug internationally. Generic drugs are required to have the same active ingredient, strength, dosage form, and route of administration as the brand name product. Generic drugs do not need to contain the same inactive ingredients as the brand name product. - A PROPRIETARY (BRAND) NAME: the brand name is selected by manufacturer or distributor of the drug. It is usually shorter and easier to remember than the generic name. The brand name of a drug implies that the drug is protected by a patent (can be produced and sold only by the company holding the patent) Example: CHEMICAL (SYSTEMATIC) IUPAC NAME N-(4-hydroxyphenyl)ethanamide N-(4-hydroxyphenyl)acetamide NON-PROPRIETARY (GENERIC) NAME Approved name: BAN Paracetamol USAN Acetaminophen Official name: BAN Paracetamol USAN Acetaminophen PROPRIETARY (BRAND) NAME Tachipirina Efferalgan Zerinol Perfalgan Tylenol

DRUG NAME

WHAT IS A MEDICAL DRUG? ACTIVE INGREDIENT (PRINCIPLE): a constituent of a drug, usually an alkaloid or glycoside, that is largely responsible for conferring its characteristic therapeutic properties EXCIPIENT (BULKING AGENT): an inactive substance that serves as the vehicle or medium for a drug or other active substance. Excipients are things like colouring agents, preservatives, and fillers. ACTIVE INGREDIENT EXCIPIENT

WHAT IS A PRODRUG? A PRODRUG is usually a pharmacologically inactive derivate of a parent drug that must undergo chemical conversion by metabolic processes before becoming an active pharmacological agent. PRODRUG/DRUG TRANSFORMATION MAY BE ENZYMATIC AND NON-ENZYMATIC A prodrug might be used instead of the active drug to - mask taste or odor; minimize pain - improve how a medical drug is absorbed, distributed, metabolized, and excreted (ADME). - improve bioavailability when a drug itself is poorly absorbed from the gastrointestinal tract. - improve how selectively the drug interacts with cells or processes that are not its intended target. This reduces adverse or unintended effects of a drug, especially important in treatments like chemotherapy, which can have severe unintended and undesirable side effects.

WHAT IS A PLACEBO? A PLACEBO is a simulated or otherwise medically ineffectual treatment for a disease or other medical condition, intended to deceive the recipient. Persons given such an ineffectual treatment will often have a perceived or actual improvement in their condition, a phenomenon commonly called the placebo effect or placebo response. Several different elements contribute to the effect, and the methods of placebo administration may be as important as the administration itself. Nocebo is an inert substance or treatment that appears to cause an adverse effect on a patient or participant although it has no known biological effect.

CLASSIFICATION OF DRUGs Drugs can be classified according to multiple parameters. - CHEMICAL NATURE - SOURCE - TARGET ORGAN/SITE OF ACTION - MODE OF ACTION - THERAPEUTIC USE - PHYSIOLOGICAL SYSTEM / PHYSICAL EFFECTS Biological drugs: Drugs made in/from living organisms A biosimilar drug (biologic) is NOT exactly a bioequivalent (generic)

USE of MEDICAL DRUGS ETIOLOGY THERAPY: any medical treatment that aims at preventing or curing the causes of the disease SYMPTOMATIC THERAPY: any medical treatment that aims at reducing the signs and symptoms of the disease for the comfort and well-being of the patient, but also for reducing organic consequences and sequelae of the disease. REPLACEMENT THERAPY: any medical treatment that aims at substituting and reintegrating the missing factor underlying the disease ETIOLOGY DRUG SYMPTOMATIC DRUG REPLACEMENT DRUG

USE of MEDICAL DRUGS cont d OFF-LABEL USE: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. A patient s informed consent is requested and the MD is responsible (and can be prosecuted) for any side effect COMPASSIONED USE: also called expanded access, provides access to unapproved investigational drugs, biologics and medical devices for patients with life-threatening conditions. According to The European Medicines Agency (EMA), compassionate use is defined as the use of an unauthorized medicine outside a clinical trial in individual patients under strictly controlled conditions. It requires approval from the Ethic Committee and the MD accepts all the legal responsibilities

DRUG DISCOVERY AND DEVELOPMENT

INTERACTION DRUG BODY DISEASE INTERACTION HOST- DISEASE HOST INTERACTION DRUG - HOST DISEASE THERAPHY DRUG RESISTANCE DRUG INTERACTION DRUG-DISEASE

Receptors - intracellular receptors - membrane receptors - Channel receptors - G protein-coupled receptors - Tyrosine-kinase receptors PHARMACODYNAMICS Drug/receptor interactions - agonists and antagonists - potency and efficacy (effectiveness) - therapeutic index Drug effects - therapeutic effects - side effects - toxic effects